KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Minority Interest: 2009-2024

Historic Minority Interest for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to $340.0 million.

  • Teva Pharmaceutical Industries' Minority Interest fell 98.75% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 million, marking a year-over-year decrease of 98.75%. This contributed to the annual value of $340.0 million for FY2024, which is 45.16% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Minority Interest stood at $340.0 million for FY2024, which was down 45.16% from $620.0 million recorded in FY2023.
  • In the past 5 years, Teva Pharmaceutical Industries' Minority Interest ranged from a high of $1.0 billion in FY2020 and a low of $340.0 million during FY2024.
  • Its 3-year average for Minority Interest is $584.7 million, with a median of $620.0 million in 2023.
  • Data for Teva Pharmaceutical Industries' Minority Interest shows a maximum YoY slumped of 45.16% (in 2024) over the last 5 years.
  • Yearly analysis of 5 years shows Teva Pharmaceutical Industries' Minority Interest stood at $1.0 billion in 2020, then fell by 6.67% to $966.0 million in 2021, then declined by 17.81% to $794.0 million in 2022, then decreased by 21.91% to $620.0 million in 2023, then crashed by 45.16% to $340.0 million in 2024.